Rate My Professor Debina Sarkar

Sarkar has contributed to several impactful publications, including 'Circular RNAs: Potential Applications as Therapeutic Targets and Biomarkers in Breast Cancer' (Non-Coding RNA, 2021), 'LncRNA-Chromatin Pull-Down Using Biotin-Conjugated DNA Probes' (Methods in Molecular Biology, 2022), 'TP53 Splice Mutations Have Tumour-Independent Effects on Genomic Stability and Prognosis: An In Silico Study' (International Journal of Molecular Sciences, 2025), and 'TP53 mutation at codon 179 metabolically reprograms cancer cells to promote invasion' (2025 preprint). She has secured competitive funding, such as the Division of Health Sciences Accelerator Grant ($2,000, 2022) for circRNA prognostic studies in breast cancer, the Cancer Research Trust Professional Development Award ($3,000, 2022), and the Heart Foundation New Zealand Emerging Researcher Grant ($20,000, 2025) for investigating TP53 mutations in atherosclerosis. Additionally, she serves on the Early Career Steering Committee of the Maurice Wilkins Centre for Molecular Biodiscovery and presented a seminar on her research in the Microbiology series at the University of Otago in June 2025.